ORASURE TECHNOLOGIES, INC Payments to Acquire Debt Securities, Available-for-sale
ORASURE TECHNOLOGIES, INC (OSUR) reported Payments to Acquire Debt Securities, Available-for-sale of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-03-09
- ORASURE TECHNOLOGIES, INC payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $0.00.
- ORASURE TECHNOLOGIES, INC payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $0.00.
- ORASURE TECHNOLOGIES, INC payments to acquire debt securities, available-for-sale for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- ORASURE TECHNOLOGIES, INC payments to acquire debt securities, available-for-sale for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- ORASURE TECHNOLOGIES, INC payments to acquire debt securities, available-for-sale for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- ORASURE TECHNOLOGIES, INC payments to acquire debt securities, available-for-sale for fiscal 2024 was $53.24M, a 28.68% decline from fiscal 2023.
- ORASURE TECHNOLOGIES, INC payments to acquire debt securities, available-for-sale for fiscal 2023 was $74.65M, a 226.38% increase from fiscal 2022.
- ORASURE TECHNOLOGIES, INC payments to acquire debt securities, available-for-sale for fiscal 2022 was $22.87M, a 11.42% decline from fiscal 2021.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 10-K · filed 2026-03-09 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $27.39M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $27.39M derived: sum of 3 quarters · filed 2026-03-09 | $53.24M 10-K · filed 2026-03-09 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $27.39M derived: sum of 2 quarters · filed 2025-11-05 | $53.24M 10-Q · filed 2025-11-05 | $53.24M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | $27.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $53.24M 10-Q · filed 2025-08-06 | $53.24M derived: sum of 3 quarters · filed 2026-03-09 | $127.90M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | $25.85M 10-Q · filed 2025-05-07 | $25.85M derived: sum of 2 quarters · filed 2026-03-09 | $100.50M derived: sum of 3 quarters · filed 2026-03-09 | $78.17M derived: sum of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $74.65M derived: sum of 2 quarters · filed 2026-03-09 | $52.32M derived: sum of 3 quarters · filed 2026-03-09 | $74.65M 10-K · filed 2026-03-09 |
| 2023-09-30 | $74.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $52.32M derived: sum of 2 quarters · filed 2024-11-06 | $74.65M 10-Q · filed 2024-11-06 | $74.65M derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-06-30 | -$22.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $0.00 derived: sum of 3 quarters · filed 2025-03-07 | |
| 2023-03-31 | $22.33M 10-Q · filed 2024-05-09 | $22.33M derived: sum of 2 quarters · filed 2025-03-07 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $22.87M 10-K · filed 2025-03-07 | ||
| 2022-09-30 | $22.87M 10-Q · filed 2023-11-08 | |||
| 2021-12-31 | $379.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $15.39M derived: sum of 2 quarters · filed 2024-03-11 | $25.82M 10-K · filed 2024-03-11 | |
| 2021-09-30 | $15.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $25.44M 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $10.43M 10-Q · filed 2022-08-09 | |||
| 2020-12-31 | $90.14M 10-K · filed 2023-03-03 | |||
| 2019-12-31 | $92.17M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |